ABSORPTION, EXCRETION AND METABOLISM OF TIQUIZIUM BROMIDE IN DOGS, AND RELATIONSHIP BETWEEN PHARMACOLOGICAL EFFECT AND PLASMA-LEVELS OF UNCHANGED DRUG

被引：11

作者：

NISHIKAWA, T ^{[1
]}

NAGATA, O ^{[1
]}

TANBO, K ^{[1
]}

YAMADA, T ^{[1
]}

TAKAHARA, Y ^{[1
]}

KATO, H ^{[1
]}

YAMAMOTO, Y ^{[1
]}

机构：

[1] KANAZAWA UNIV,FAC PHARMACEUT SCI,KANAZAWA,ISHIKAWA 920,JAPAN

来源：

XENOBIOTICA | 1985年 / 15卷 / 12期

关键词：

D O I：

10.3109/00498258509049100

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1053 / 1060

页数：8

共 8 条

[1]

KOSHINAKA E, 1979, CHEM PHARM BULL, V27, P1454

[2] PHARMACOLOGICAL STUDIES ON ANTISPASMODICS .4. GANGLION BLOCKING ACTIVITY OF 3-(DI-2-THIENYLMETHYLENE)-5-METHYL-TRANS-QUINOLIZIDIUM BROMIDE (HSR-902) AND THE CORRELATION BETWEEN ITS BLOCKING ACTIVITY AND ITS INHIBITORY ACTIVITY TOWARDS URINARY-BLADDER CONTRACTION [J].

KUBO, S ;

MORIKAWA, K ;

YAMAZAKI, M ;

MATSUBARA, I ;

KATO, H .

FOLIA PHARMACOLOGICA JAPONICA, 1981, 78 (05) :483-490

[3] PHARMACOLOGICAL STUDIES ON ANTISPASMODICS .1. SELECTIVITY TO ANTI-SPASMODIC ACTIVITY OF DIARYLMETHYLENE-5-METHYL-TRANS-QUINOLIZIDINIUM BROMIDES [J].

KUBO, S ;

MORIKAWA, K ;

YAMAZAKI, M ;

KASAMATSU, S ;

KOSHINAKA, E ;

KATO, H .

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1981, 101 (02) :174-181

[4]

LEVY G, 1966, CLIN PHARMACOL THER, V7, P362

[5]

Takahara Y., 1982, Pharmacometrics, V23, P795

[6]

TAKAHARA Y, 1982, OYO YAKURI, V23, P789

[7] QUANTITATIVE-DETERMINATION OF TIQUIZIUM BROMIDE IN HUMAN-SERUM AND URINE BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

YAMADA, T ;

NAGATA, O ;

SATO, E ;

NISHIKAWA, T ;

ITO, Y .

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1983, 103 (12) :1319-1322

[8]

YAMAMOTO Y, 1985, IYAKUHIN KENKYU, V16, P207

← 1 →